Fig. 1From: A paclitaxel-hyaluronan conjugate (ONCOFID-P-B™) in patients with BCG-unresponsive carcinoma in situ of the bladder: a dynamic assessment of the tumor microenvironmentTrial profile and samples collection timeline. Created with BioRender.comBack to article page